Nat Rev Neurol

• 

  Publication Venue For

  • Parkinson disease and the immune system - associations, mechanisms and therapeutics..  16:303-318. 2020
  • Improved grading of IDH-mutated astrocytic gliomas..  14:383-384. 2018
  • Tuberculous meningitis..  13:581-598. 2017
  • Vaccine-based immunotherapeutic approaches to gliomas and beyond..  13:363-374. 2017
  • CAP--advancing the evaluation of preclinical Alzheimer disease treatments..  12:56-61. 2016
  • Prospects of immune checkpoint modulators in the treatment of glioblastoma..  11:504-514. 2015
  • Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?.  11:429-430. 2015
  • Classifying neurocognitive disorders: the DSM-5 approach..  10:634-642. 2014
  • Preimplantation genetic diagnosis for inherited neurological disorders..  10:417-424. 2014
  • Neuro-oncology: Glioblastoma--community adjusts to new standard of care..  8:244-246. 2012
  • Stroke: Organizing the disorganized: improving TIA patient care..  7:190-192. 2011
  • Neuro-oncology: unmasking the multiforme in glioblastoma..  6:304-305. 2010
  • Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma..  5:646-647. 2009